{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:37:00Z","timestamp":1790426220407,"version":"4.1.0"},"reference-count":155,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"abstract":"<jats:p>The overlabeling of pediatric antibiotic allergy represents a huge burden in society. Given that up to 10% of the US population is labeled as penicillin allergic, it can be estimated that at least 5 million children in this country are labeled with penicillin allergy. We now understand that most of the cutaneous symptoms that are interpreted as drug allergy are likely viral induced or due to a drug\u2013virus interaction, and they usually do not represent a long-lasting, drug-specific, adaptive immune response to the antibiotic that a child received. Because most antibiotic allergy labels acquired in childhood are carried into adulthood, the overlabeling of antibiotic allergy is a liability that leads to unnecessary long-term health care risks, costs, and antibiotic resistance. Fortunately, awareness of this growing burden is increasing and leading to more emphasis on antibiotic allergy delabeling strategies in the adult population. There is growing literature that is used to support the safe and efficacious use of tools such as skin testing and drug challenge to evaluate and manage children with antibiotic allergy labels. In addition, there is an increasing understanding of antibiotic reactivity within classes and side-chain reactions. In summary, a better overall understanding of the current tools available for the diagnosis and management of adverse drug reactions is likely to change how pediatric primary care providers evaluate and treat patients with such diagnoses and prevent the unnecessary avoidance of antibiotics, particularly penicillins.<\/jats:p>","DOI":"10.1542\/peds.2017-2497","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T03:25:17Z","timestamp":1524713117000},"source":"Crossref","is-referenced-by-count":115,"title":["Antibiotic Allergy in Pediatrics"],"prefix":"10.1542","volume":"141","author":[{"given":"Allison Eaddy","family":"Norton","sequence":"first","affiliation":[{"name":"Division of Allergy, Immunology and Pulmonology, Monroe Carell Jr. Children's Hospital at Vanderbilt, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Konvinse","sequence":"additional","affiliation":[{"name":"Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology and Pulmonology, Monroe Carell Jr. Children's Hospital at Vanderbilt, and"},{"name":"Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee;"},{"name":"John A. Oates Institute for Experimental Therapeutics and Department of Pharmacology, School of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee;"},{"name":"Division of Infectious Disease, Departments of Medicine and"},{"name":"Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Dioun","family":"Broyles","sequence":"additional","affiliation":[{"name":"Division of Allergy and Immunology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"issue":"3","key":"2021121021520486500_B1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.acap.2016.11.004","article-title":"Parent-reported penicillin allergy symptoms in the pediatric emergency department.","volume":"17","author":"Vyles","year":"2017","journal-title":"Acad Pediatr"},{"key":"2021121021520486500_B2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/B978-0-323-29875-9.00055-0","article-title":"Drug Allergy","volume-title":"Pediatric Allergy: Principles and Practice","author":"Chiriac","year":"2016","edition":"3rd ed"},{"issue":"7","key":"2021121021520486500_B3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/cid\/ciw462","article-title":"Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study.","volume":"63","author":"MacFadden","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2021121021520486500_B4","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2013.09.021","article-title":"Health care use and serious infection prevalence associated with penicillin \u201callergy\u201d in hospitalized patients: a cohort study.","volume":"133","author":"Macy","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2021121021520486500_B5","doi-asserted-by":"crossref","first-page":"e20170471","DOI":"10.1542\/peds.2017-0471","article-title":"Allergy testing in children with low-risk penicillin allergy symptoms.","volume":"140","author":"Vyles","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"2021121021520486500_B6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2222.2007.02870.x","article-title":"Drug allergy claims in children: from self-reporting to confirmed diagnosis.","volume":"38","author":"Rebelo Gomes","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"2021121021520486500_B7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2500\/aap.2014.35.3744","article-title":"The evaluation of drug provocation tests in pediatric allergy clinic: a single center experience.","volume":"35","author":"Vezir","year":"2014","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"2021121021520486500_B8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2500\/aap.2012.33.3510","article-title":"Outpatient penicillin use after negative skin testing and drug challenge in a pediatric population.","volume":"33","author":"Picard","year":"2012","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"2021121021520486500_B9","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaip.2015.05.019","article-title":"Penicillin allergy label persists despite negative testing.","volume":"3","author":"Gerace","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"2021121021520486500_B10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archfami.9.8.722","article-title":"Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergy.","volume":"9","author":"MacLaughlin","year":"2000","journal-title":"Arch Fam Med"},{"issue":"19","key":"2021121021520486500_B11","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1001\/jama.2010.1651","article-title":"Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review.","volume":"304","author":"Coker","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"2021121021520486500_B12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/ACI.0b013e32825ea68a","article-title":"Drug hypersensitivity in HIV.","volume":"7","author":"Phillips","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"2021121021520486500_B13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2045-7022-2-10","article-title":"Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics.","volume":"2","author":"Caimmi","year":"2012","journal-title":"Clin Transl Allergy"},{"issue":"4","key":"2021121021520486500_B14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.anai.2016.07.039","article-title":"Approach to the evaluation of adverse antibiotic reactions in patients with cystic fibrosis.","volume":"117","author":"Petroni","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"2021121021520486500_B15","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1542\/peds.2004-1276","article-title":"A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients.","volume":"115","author":"Pichichero","year":"2005","journal-title":"Pediatrics"},{"issue":"3","key":"2021121021520486500_B16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jpeds.2007.07.041","article-title":"National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.","volume":"152","author":"Cohen","year":"2008","journal-title":"J Pediatr"},{"issue":"5","key":"2021121021520486500_B17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2165\/11587540-000000000-00000","article-title":"Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.","volume":"34","author":"Star","year":"2011","journal-title":"Drug Saf"},{"issue":"2","key":"2021121021520486500_B18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.2005-2429","article-title":"Adverse drug reactions among children over a 10-year period.","volume":"118","author":"Le","year":"2006","journal-title":"Pediatrics"},{"issue":"4","key":"2021121021520486500_B19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.all.0000173785.81024.33","article-title":"Epidemiology of hypersensitivity drug reactions.","volume":"5","author":"Gomes","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"15","key":"2021121021520486500_B20","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/ajhp\/58.15.1413","article-title":"Multidisciplinary education and management program for children with asthma.","volume":"58","author":"Chan","year":"2001","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"2021121021520486500_B21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1742-1241.1994.tb09729.x","article-title":"Penicillin allergy: a study of incidence as reported by patients.","volume":"48","author":"Kerr","year":"1994","journal-title":"Br J Clin Pract"},{"issue":"3","key":"2021121021520486500_B22","doi-asserted-by":"crossref","first-page":"e24061","DOI":"10.1371\/journal.pone.0024061","article-title":"Adverse drug reactions in children\u2014a systematic review.","volume":"7","author":"Smyth","year":"2012","journal-title":"PLoS One"},{"issue":"20","key":"2021121021520486500_B23","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.1993.03510200062033","article-title":"Clinical experience with penicillin skin testing in a large inner-city STD clinic.","volume":"270","author":"Gadde","year":"1993","journal-title":"JAMA"},{"issue":"8","key":"2021121021520486500_B24","doi-asserted-by":"crossref","first-page":"778.e1","DOI":"10.1016\/j.amjmed.2009.01.034","article-title":"Self-reported antibiotic allergy incidence and prevalence: age and sex effects.","volume":"122","author":"Macy","year":"2009","journal-title":"Am J Med"},{"issue":"2","key":"2021121021520486500_B25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2500\/aap.2014.35.3744","article-title":"The evaluation of drug provocation tests in pediatric allergy clinic: a single center experience.","volume":"35","author":"Vezir","year":"2014","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"2021121021520486500_B26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1399-3038.2011.01169.x","article-title":"Allergy to beta-lactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests.","volume":"22","author":"Ponvert","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"issue":"10","key":"2021121021520486500_B27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/INF.0b013e3182624d03","article-title":"Evaluating the usefulness of retesting for beta-lactam allergy in children.","volume":"31","author":"Iglesias-Souto","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"2021121021520486500_B28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaci.2011.11.027","article-title":"A suspicion of antibiotic allergy in children is often incorrect.","volume":"129","author":"Mattheij","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2021121021520486500_B29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1399-3038.2011.01134.x","article-title":"Diagnosis of drug hypersensitivity in children and adolescents: discrepancy between physician-based assessment and results of testing.","volume":"22","author":"Seitz","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"issue":"12","key":"2021121021520486500_B30","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7326\/0003-4819-140-12-200406150-00009","article-title":"Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction.","volume":"140","author":"Messaad","year":"2004","journal-title":"Ann Intern Med"},{"issue":"1","key":"2021121021520486500_B31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaci.2010.08.025","article-title":"The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge.","volume":"127","author":"Caubet","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2021121021520486500_B32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/QCO.0b013e3283523f8b","article-title":"Managing possible antibiotic allergy in children.","volume":"25","author":"Caubet","year":"2012","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"2021121021520486500_B33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/pai.12047","article-title":"Prevalence of confirmed immediate type drug hypersensitivity reactions among school children.","volume":"24","author":"Erko\u00e7o\u011flu","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"2021121021520486500_B34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jama.2017.6510","article-title":"Penicillin allergy is not necessarily forever.","volume":"318","author":"Trubiano","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"2021121021520486500_B35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/pai.12565","article-title":"Non-immediate hypersensitivity reactions to beta-lactam antibiotics in children - our 10-year experience in allergy work-up.","volume":"27","author":"Atanaskovic-Markovic","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"2021121021520486500_B36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11096-015-0100-9","article-title":"Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests.","volume":"37","author":"Arikoglu","year":"2015","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"2021121021520486500_B37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.aller.2010.01.005","article-title":"Drug provocation tests to betalactam antibiotics: experience in a paediatric setting.","volume":"38","author":"Chambel","year":"2010","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"1","key":"2021121021520486500_B38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaip.2013.11.006","article-title":"Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis.","volume":"2","author":"Romano","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"2021121021520486500_B39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archderm.136.7.849","article-title":"Antibiotic rashes in children: a survey in a private practice setting.","volume":"136","author":"Ibia","year":"2000","journal-title":"Arch Dermatol"},{"issue":"6","key":"2021121021520486500_B40","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jaci.2012.08.021","article-title":"Allergy to \u03b2-lactam antibiotics.","volume":"130","author":"Solensky","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"2021121021520486500_B41","volume-title":"WAO White Book on Allergy 2011-2012 Executive Summary","author":"Pawankar","year":"2011"},{"issue":"2","key":"2021121021520486500_B42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaci.2009.11.032","article-title":"Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions.","volume":"125","author":"Torres","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2021121021520486500_B43","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/pai.12155","article-title":"Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children.","volume":"25","author":"Zambonino","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"2021121021520486500_B44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/all.12774","article-title":"Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group.","volume":"71","author":"Gomes","year":"2016","journal-title":"Allergy"},{"issue":"2","key":"2021121021520486500_B45","first-page":"128","article-title":"Azithromycin is more allergenic than clarithromycin in children with suspected hypersensitivity reaction to macrolides.","volume":"25","author":"Barni","year":"2015","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"2021121021520486500_B46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/039463201402700116","article-title":"Azithromycin anaphylaxis in children.","volume":"27","author":"Mori","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"4","key":"2021121021520486500_B47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter.","volume":"105","author":"Joint Task Force on Practice Parameters","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"2021121021520486500_B48","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review.","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"issue":"19","key":"2021121021520486500_B49","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs.","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"2021121021520486500_B50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/pai.12353","article-title":"Trimethoprim-sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl.","volume":"26","author":"G\u00f3mez-Traseira","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"2021121021520486500_B51","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","article-title":"Epidemiology and risk factors for drug allergy.","volume":"71","author":"Thong","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"2021121021520486500_B52","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/bcp.13294","article-title":"Pharmacogenomics of off-target adverse drug reactions.","volume":"83","author":"Garon","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"2021121021520486500_B53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response.","volume":"136","author":"White","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2021121021520486500_B54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/bcp.12749","article-title":"Classifying ADRs\u2014does dose matter?","volume":"81","author":"Phillips","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2021121021520486500_B55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11882-011-0239-y","article-title":"Management of multiple drug allergies in children.","volume":"12","author":"Dioun","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"2021121021520486500_B56","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/ACI.0b013e328355b7b1","article-title":"Diagnostic issues in pediatric drug allergy.","volume":"12","author":"Caubet","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"7542","key":"2021121021520486500_B57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"issue":"1","key":"2021121021520486500_B58","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/itx.0000000000000005","article-title":"Brief communication: MRGPRX2, atopic dermatitis and red man syndrome.","volume":"2","author":"Azimi","year":"2017","journal-title":"Itch (Phila)"},{"key":"2021121021520486500_B59","first-page":"575","volume-title":"Clinical Aspects of Immunology","author":"Gell","year":"1968"},{"issue":"8","key":"2021121021520486500_B60","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions.","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann Intern Med"},{"issue":"1","key":"2021121021520486500_B61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2332\/allergolint.55.17","article-title":"Pharmacological interaction of drugs with immune receptors: the p-i concept.","volume":"55","author":"Pichler","year":"2006","journal-title":"Allergol Int"},{"issue":"15","key":"2021121021520486500_B62","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2217\/pgs.14.147","article-title":"Pharmacogenomics of antimicrobial agents.","volume":"15","author":"Aung","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"6","key":"2021121021520486500_B63","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/QCO.0000000000000006","article-title":"Antimicrobial stewardship\u2019s new weapon? A review of antibiotic allergy and pathways to \u2018de-labeling\u2019.","volume":"26","author":"Trubiano","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"7","key":"2021121021520486500_B64","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/all.13132","article-title":"Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology.","volume":"72","author":"Muraro","year":"2017","journal-title":"Allergy"},{"issue":"8","key":"2021121021520486500_B65","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/all.12636","article-title":"Selective immediate responders to amoxicillin and clavulanic acid tolerate penicillin derivative administration after confirming the diagnosis.","volume":"70","author":"Blanca-Lopez","year":"2015","journal-title":"Allergy"},{"issue":"4","key":"2021121021520486500_B66","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijantimicag.2016.08.001","article-title":"Allergy to antibiotics in children: an overestimated problem.","volume":"48","author":"Esposito","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"2021121021520486500_B67","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/cea.12099","article-title":"Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved.","volume":"43","author":"Blanca-L\u00f3pez","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"2021121021520486500_B68","first-page":"393","article-title":"In vivo diagnostic tests in adverse reactions to quinolones.","volume":"17","author":"Venturini D\u00edaz","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"5","key":"2021121021520486500_B69","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.anai.2014.02.005","article-title":"Penicillin and cephalosporin allergy.","volume":"112","author":"Pichichero","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"2021121021520486500_B70","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jaci.2015.03.012","article-title":"IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of alternative cephalosporins.","volume":"136","author":"Romano","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2021121021520486500_B71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11882-016-0594-9","article-title":"Cross-reactivity among beta-lactams.","volume":"16","author":"Romano","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"2021121021520486500_B72","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1398-9995.1994.tb00809.x","article-title":"Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross-reactivity with cephalosporin.","volume":"49","author":"Audicana","year":"1994","journal-title":"Allergy"},{"issue":"3","key":"2021121021520486500_B73","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1365-2222.2001.00992.x","article-title":"Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins.","volume":"31","author":"Novalbos","year":"2001","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"2021121021520486500_B74","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaci.2005.10.032","article-title":"Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins.","volume":"117","author":"Antunez","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2021121021520486500_B75","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jaci.2010.06.052","article-title":"IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of penicillins, monobactams, and carbapenems.","volume":"126","author":"Romano","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2021121021520486500_B76","doi-asserted-by":"crossref","first-page":"e160033","DOI":"10.1001\/jamapediatrics.2016.0033","article-title":"Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children.","volume":"170","author":"Mill","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"4","key":"2021121021520486500_B77","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaip.2016.02.008","article-title":"Antibiotics are the most commonly identified cause of perioperative hypersensitivity reactions.","volume":"4","author":"Kuhlen","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"2021121021520486500_B78","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.anai.2016.10.025","article-title":"Epidemiology of anaphylaxis at a tertiary care center: a report of 730 cases.","volume":"118","author":"Gonzalez-Estrada","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"2021121021520486500_B79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaip.2014.11.005","article-title":"Antibiotics are an important identifiable cause of perioperative anaphylaxis in the United States.","volume":"3","author":"Gonzalez-Estrada","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"2021121021520486500_B80","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaip.2015.11.003","article-title":"A predictive model for the diagnosis of allergic drug reactions according to the medical history.","volume":"4","author":"Hierro Santurino","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"2021121021520486500_B81","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2009.02.031","article-title":"Tolerability of imipenem in children with IgE-mediated hypersensitivity to penicillins.","volume":"124","author":"Atanaskovi\u0107-Markovi\u0107","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"2021121021520486500_B82","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/all.12299","article-title":"Absence of cross-reactivity to carbapenems in patients with delayed hypersensitivity to penicillins.","volume":"68","author":"Romano","year":"2013","journal-title":"Allergy"},{"issue":"1","key":"2021121021520486500_B83","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2016.01.025","article-title":"Cross-reactivity and tolerability of aztreonam and cephalosporins in subjects with a T cell-mediated hypersensitivity to penicillins.","volume":"138","author":"Romano","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2021121021520486500_B84","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1398-9995.2007.01532.x","article-title":"Tolerability of meropenem in children with IgE-mediated hypersensitivity to penicillins.","volume":"63","author":"Atanaskovi\u0107-Markovi\u0107","year":"2008","journal-title":"Allergy"},{"key":"2021121021520486500_B85","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jaci.2010.11.047","article-title":"Diagnosis and management of drug hypersensitivity reactions.","volume":"127","author":"Romano","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2021121021520486500_B86","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2222.2011.03887.x","article-title":"Results of drug hypersensitivity evaluations in a large group of children and adults.","volume":"42","author":"Rubio","year":"2012","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"2021121021520486500_B87","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2005-2321","article-title":"Cutaneous reactions to drugs in children.","volume":"120","author":"Segal","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"2021121021520486500_B88","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaip.2017.01.025","article-title":"Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice.","volume":"5","author":"Peter","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"2021121021520486500_B89","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy.","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"issue":"1","key":"2021121021520486500_B90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-4362.2001.00081.x","article-title":"Which intercurrent infections are associated with maculopapular cutaneous drug reactions? A case-control study.","volume":"40","author":"Cohen","year":"2001","journal-title":"Int J Dermatol"},{"issue":"17","key":"2021121021520486500_B91","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa022963","article-title":"Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics.","volume":"349","author":"Strom","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121021520486500_B92","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0022-3476(73)80328-2","article-title":"Adverse effects of orally administered ampicillin.","volume":"83","author":"Bass","year":"1973","journal-title":"J Pediatr"},{"issue":"6","key":"2021121021520486500_B93","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/pai.12273","article-title":"Hypersensitivity reactions to non-betalactam antibiotics in children: an extensive review.","volume":"25","author":"Kuyucu","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"issue":"8","key":"2021121021520486500_B94","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/all.12886","article-title":"In vitro tests for drug hypersensitivity reactions: an ENDA\/EAACI Drug Allergy Interest Group position paper.","volume":"71","author":"Mayorga","year":"2016","journal-title":"Allergy"},{"issue":"11","key":"2021121021520486500_B95","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1398-9995.2004.00678.x","article-title":"Diagnosis of nonimmediate reactions to \u03b2-lactam antibiotics.","volume":"59","author":"Romano","year":"2004","journal-title":"Allergy"},{"issue":"10","key":"2021121021520486500_B96","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1034\/j.1398-9995.2003.00280.x","article-title":"Diagnosis of immediate allergic reactions to beta-lactam antibiotics.","volume":"58","author":"Torres","year":"2003","journal-title":"Allergy"},{"key":"2021121021520486500_B97","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.2500\/aap.2012.33.3563","article-title":"Chapter 30: drug allergy.","volume":"33","author":"Greenberger","year":"2012","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"2021121021520486500_B98","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2222.2008.03155.x","article-title":"BSACI guidelines for the management of drug allergy.","volume":"39","author":"Mirakian","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"9","key":"2021121021520486500_B99","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1034\/j.1398-9995.1999.00247.x","article-title":"Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity.","volume":"54","author":"Demoly","year":"1999","journal-title":"Allergy"},{"key":"2021121021520486500_B100","article-title":"Management of drug hypersensitivity in the pediatric population [published online ahead of print July 28, 2016].","author":"Atanaskovic-Markovic","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"2021121021520486500_B101","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/ACI.0000000000000069","article-title":"Allergic reactions to antibiotics in children.","volume":"14","author":"Fernandez","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"2021121021520486500_B102","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-3476(98)70499-8","article-title":"Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge.","volume":"132","author":"Pichichero","year":"1998","journal-title":"J Pediatr"},{"key":"2021121021520486500_B103","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jaci.2009.10.028","article-title":"Drug allergy.","volume":"125","author":"Khan","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2021121021520486500_B104","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1399-3038.2005.00280.x","article-title":"Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children.","volume":"16","author":"Atanaskovi\u0107-Markovi\u0107","year":"2005","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"2021121021520486500_B105","doi-asserted-by":"crossref","DOI":"10.1542\/peds.104.4.e45","article-title":"Allergy to beta-lactam antibiotics in children.","volume":"104","author":"Ponvert","year":"1999","journal-title":"Pediatrics"},{"issue":"2","key":"2021121021520486500_B106","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1398-9995.2008.01924.x","article-title":"Update on the evaluation of hypersensitivity reactions to betalactams.","volume":"64","author":"Blanca","year":"2009","journal-title":"Allergy"},{"issue":"6","key":"2021121021520486500_B107","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs \u2013 an ENDA\/EAACI Drug Allergy Interest Group position paper.","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"issue":"3","key":"2021121021520486500_B108","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0091-6749(03)01783-4","article-title":"Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics.","volume":"112","author":"Empedrad","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"2021121021520486500_B109","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-3-540-33395-1","volume-title":"Pediatric Allergy, Asthma and Immunology","author":"Cantani","year":"2008","edition":"1st ed."},{"issue":"1","key":"2021121021520486500_B110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1398-9995.2006.01246.x","article-title":"Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge tests.","volume":"62","author":"Ponvert","year":"2007","journal-title":"Allergy"},{"issue":"8","key":"2021121021520486500_B111","first-page":"868","article-title":"Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007).","volume":"78","author":"Dong","year":"2012","journal-title":"Minerva Anestesiol"},{"issue":"1","key":"2021121021520486500_B112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.anai.2016.04.017","article-title":"In vitro rapid diagnostic tests for severe drug hypersensitivity reactions in children.","volume":"117","author":"Haw","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"2021121021520486500_B113","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaci.2012.11.017","article-title":"False-positive penicillin immunoassay: an unnoticed common problem.","volume":"132","author":"Johansson","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2021121021520486500_B114","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/2045-7022-4-34","article-title":"Positive serum specific IgE has a short half-life in patients with penicillin allergy and reversal does not always indicate tolerance.","volume":"4","author":"Hjortlund","year":"2014","journal-title":"Clin Transl Allergy"},{"issue":"8","key":"2021121021520486500_B115","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/cea.12743","article-title":"Dynamics of plasma levels of specific IgE in chlorhexidine allergic patients with and without accidental re-exposure.","volume":"46","author":"Opstrup","year":"2016","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"2021121021520486500_B116","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/07853890701449354","article-title":"Triggers of IgE class switching and allergy development.","volume":"39","author":"Poulsen","year":"2007","journal-title":"Ann Med"},{"issue":"2","key":"2021121021520486500_B117","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1398-9995.2010.02460.x","article-title":"In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones.","volume":"66","author":"Aranda","year":"2011","journal-title":"Allergy"},{"issue":"4","key":"2021121021520486500_B118","first-page":"278","article-title":"Basophil activation and sulfidoleukotriene production in patients with immediate allergy to betalactam antibiotics and negative skin tests.","volume":"14","author":"Gamboa","year":"2004","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"2021121021520486500_B119","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.iac.2009.04.011","article-title":"The basophil activation test in immediate-type drug allergy.","volume":"29","author":"Hausmann","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"issue":"11","key":"2021121021520486500_B120","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/j.1365-2222.2004.02110.x","article-title":"The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams.","volume":"34","author":"Torres","year":"2004","journal-title":"Clin Exp Allergy"},{"issue":"9","key":"2021121021520486500_B121","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/cea.12145","article-title":"In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test.","volume":"43","author":"Porebski","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"2021121021520486500_B122","first-page":"15","article-title":"Testing for drug hypersensitivity syndromes.","volume":"34","author":"Rive","year":"2013","journal-title":"Clin Biochem Rev"},{"issue":"12","key":"2021121021520486500_B123","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/cea.12437","article-title":"Aminopenicillin-associated exanthem: lymphocyte transformation testing revisited.","volume":"44","author":"Trautmann","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"2021121021520486500_B124","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jaci.2012.05.042","article-title":"Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug.","volume":"130","author":"Bensaid","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2021121021520486500_B125","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/jpet.111.190900","article-title":"Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis.","volume":"341","author":"El-Ghaiesh","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"2021121021520486500_B126","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/tx400124m","article-title":"\u03b2-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis.","volume":"26","author":"Jenkins","year":"2013","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"2021121021520486500_B127","first-page":"131","article-title":"Cytokine expression profile of sensitized human T lymphocytes following in vitro stimulation with amoxicillin.","volume":"19","author":"Khalil","year":"2008","journal-title":"Eur Cytokine Netw"},{"issue":"6","key":"2021121021520486500_B128","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4168\/aair.2013.5.6.415","article-title":"A case of sulfasalazine-induced hypersensitivity syndrome confirmed by enzyme-linked immunospot assay.","volume":"5","author":"Phatharacharukul","year":"2013","journal-title":"Allergy Asthma Immunol Res"},{"issue":"4","key":"2021121021520486500_B129","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1398-9995.2008.01674.x","article-title":"Detection and quantification of drug-specific T cells in penicillin allergy.","volume":"64","author":"Rozieres","year":"2009","journal-title":"Allergy"},{"issue":"1","key":"2021121021520486500_B130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2340\/00015555-1386","article-title":"The potential of using enzyme-linked immunospot to diagnose cephalosporin-induced maculopapular exanthems.","volume":"93","author":"Tanvarasethee","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"2021121021520486500_B131","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jim.2005.07.014","article-title":"Monitoring of cellular responses after vaccination against tetanus toxoid: comparison of the measurement of IFN-gamma production by ELISA, ELISPOT, flow cytometry and real-time PCR.","volume":"305","author":"Tassignon","year":"2005","journal-title":"J Immunol Methods"},{"issue":"3","key":"2021121021520486500_B132","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jaip.2016.09.043","article-title":"Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis.","volume":"5","author":"Trubiano","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"2021121021520486500_B133","doi-asserted-by":"crossref","first-page":"e00078","DOI":"10.1128\/AAC.00078-17","article-title":"Antibiotic allergy labels in a liver transplant recipient study.","volume":"61","author":"Khumra","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021121021520486500_B134","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13756-015-0063-6","article-title":"The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients.","volume":"4","author":"Trubiano","year":"2015","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"2021121021520486500_B135","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1081-1206(10)61778-4","article-title":"Antibiotic desensitization for the allergic patient: 5 years of experience and practice.","volume":"92","author":"Turvey","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"2021121021520486500_B136","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.iac.2009.04.012","article-title":"Rapid desensitization for hypersensitivity reactions to medications.","volume":"29","author":"Castells","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"2021121021520486500_B137","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/pai.12001","article-title":"Desensitization to antibiotics in children.","volume":"24","author":"Cernadas","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"2021121021520486500_B138","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/pai.12525","article-title":"Successful desensitization in a child with delayed cotrimoxazole hypersensitivity: a case report.","volume":"27","author":"D\u2019Amelio","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"2021121021520486500_B139","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jaip.2013.01.013","article-title":"Successful clarithromycin desensitization in a macrolide-sensitive pediatric patient.","volume":"1","author":"Petitto","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"2021121021520486500_B140","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/pai.12191","article-title":"Successful rifampin desensitization in a pediatric patient with latent tuberculosis.","volume":"25","author":"Logsdon","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"2021121021520486500_B141","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1081\/JAS-120037650","article-title":"Nonsteroidal anti-inflammatory drug-induced reactions and desensitization.","volume":"41","author":"Berges-Gimeno","year":"2004","journal-title":"J Asthma"},{"issue":"6, pt 1","key":"2021121021520486500_B142","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0091-6749(98)70343-4","article-title":"Six-hour trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients.","volume":"102","author":"Demoly","year":"1998","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2021121021520486500_B143","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/ped.2015.0615","article-title":"Rituximab desensitization in pediatric patients: results of a case series.","volume":"29","author":"Dilley","year":"2016","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"6","key":"2021121021520486500_B144","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jaci.2009.09.009","article-title":"Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.","volume":"124","author":"Brennan","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"2021121021520486500_B145","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/all.12161","article-title":"Desensitization in delayed drug hypersensitivity reactions \u2013 an EAACI position paper of the Drug Allergy Interest Group.","volume":"68","author":"Scherer","year":"2013","journal-title":"Allergy"},{"issue":"1","key":"2021121021520486500_B146","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/cid\/cix244","article-title":"Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: a multicenter evaluation.","volume":"65","author":"Trubiano","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2021121021520486500_B147","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jhm.2083","article-title":"Risk of redocumenting penicillin allergy in a cohort of patients with negative penicillin skin tests.","volume":"8","author":"Rimawi","year":"2013","journal-title":"J Hosp Med"},{"key":"2021121021520486500_B148","doi-asserted-by":"crossref","first-page":"AB183","DOI":"10.1016\/j.jaci.2016.12.597","article-title":"Effectiveness of interventions to maintain penicillin allergy label removal as part of an inpatient penicillin allergy testing protocol.","volume":"139","author":"Patel","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2021121021520486500_B149","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11882-017-0706-1","article-title":"Evaluation of penicillin allergy in the hospitalized patient: opportunities for antimicrobial stewardship.","volume":"17","author":"Chen","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"2021121021520486500_B150","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jaip.2016.09.045","article-title":"A proactive approach to penicillin allergy testing in hospitalized patients.","volume":"5","author":"Chen","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"2021121021520486500_B151","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.anai.2015.05.011","article-title":"Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy.","volume":"115","author":"Blumenthal","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"2021121021520486500_B152","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jaip.2017.02.019","article-title":"Addressing inpatient beta-lactam allergies: a multihospital implementation.","volume":"5","author":"Blumenthal","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"2021121021520486500_B153","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jaci.2017.02.005","article-title":"Tackling inpatient penicillin allergies: assessing tools for antimicrobial stewardship.","volume":"140","author":"Blumenthal","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2021121021520486500_B154","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.aller.2010.10.002","article-title":"Short protocol for the study of paediatric patients with suspected betalactam antibiotic hypersensitivity and low risk criteria.","volume":"39","author":"Moral","year":"2011","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"3","key":"2021121021520486500_B155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaip.2014.11.001","article-title":"Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions.","volume":"3","author":"Mori","year":"2015","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-2497\/1065675\/peds_20172497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-2497\/1065675\/peds_20172497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T05:24:24Z","timestamp":1720243464000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/141\/5\/e20172497\/37932\/Antibiotic-Allergy-in-Pediatrics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":155,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,1]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2017-2497","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,1]]},"article-number":"e20172497"}}